Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation.
Monforte V, Ussetti P, Gavaldà J, Bravo C, Laporta R, Len O, García-Gallo CL, Tenorio L, Solé J, Román A. Monforte V, et al. Among authors: ussetti p. J Heart Lung Transplant. 2010 May;29(5):523-30. doi: 10.1016/j.healun.2009.11.603. Epub 2010 Jan 12. J Heart Lung Transplant. 2010. PMID: 20061165 Clinical Trial.
Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant.
Monforte V, López-Sánchez A, Zurbano F, Ussetti P, Solé A, Casals C, Cifrian J, de Pablos A, Bravo C, Román A. Monforte V, et al. Among authors: ussetti p. J Heart Lung Transplant. 2013 Mar;32(3):313-9. doi: 10.1016/j.healun.2012.11.013. Epub 2013 Jan 16. J Heart Lung Transplant. 2013. PMID: 23332731
Results of clinical lung transplant from uncontrolled non-heart-beating donors.
de Antonio DG, Marcos R, Laporta R, Mora G, García-Gallo C, Gámez P, Córdoba M, Moradiellos J, Ussetti P, Carreño MC, Núñez JR, Calatayud J, Del Río F, Varela A. de Antonio DG, et al. Among authors: ussetti p. J Heart Lung Transplant. 2007 May;26(5):529-34. doi: 10.1016/j.healun.2007.01.028. J Heart Lung Transplant. 2007. PMID: 17449425
Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study.
Monforte V, Sintes H, López-Gallo C, Delgado M, Santos F, Zurbano F, Solé A, Gavaldá J, Borro JM, Redel-Montero J, Cifrian JM, Pastor A, Román A, Ussetti P. Monforte V, et al. Among authors: ussetti p. Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12694. Epub 2017 May 9. Transpl Infect Dis. 2017. PMID: 28294487
Monitoring of early humoral immunity to identify lung recipients at risk for development of serious infections: A multicenter prospective study.
Sarmiento E, Cifrian J, Calahorra L, Bravo C, Lopez S, Laporta R, Ussetti P, Sole A, Morales C, de Pablos A, Jaramillo M, Ezzahouri I, García S, Navarro J, Lopez-Hoyos M, Carbone J. Sarmiento E, et al. Among authors: ussetti p. J Heart Lung Transplant. 2018 Aug;37(8):1001-1012. doi: 10.1016/j.healun.2018.04.001. Epub 2018 Apr 6. J Heart Lung Transplant. 2018. PMID: 29754764
Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational Study.
Monforte V, Ussetti P, Castejón R, Sintes H, Pérez VL, Laporta R, Sole A, Cifrián JM, Marcos PJ, Redel J, Arcos IL, Berastegui C, Alonso R, Rosado S, Escriva J, Iturbe D, Ovalle JP, Vaquero JM, López-Meseguer M, Mendoza A, Gómez-Ollés S. Monforte V, et al. Among authors: ussetti p. Arch Bronconeumol. 2021 Nov;57(11):690-696. doi: 10.1016/j.arbr.2020.12.012. Arch Bronconeumol. 2021. PMID: 35699006
91 results